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DCs comprise a heterogeneous group of APCs 
found throughout the body that include plas-
macytoid DCs (pDCs) and CD11chigh conven-
tional DCs (cDCs). Mouse cDCs in lymphoid 
organs include CD8+ and CD8 subsets that 
have distinct functional properties (Steinman, 
2007; Naik, 2008). DC populations present in   
nonlymphoid organs also include several unique 
DC subsets. Although there has been some 
progress in defining the phenotypic proper-
ties of DCs in the lung, gastrointestinal tract, 
and skin, the relationship between peripheral   
DCs and lymphoid-resident DCs is unclear   
(GeurtsvanKessel and Lambrecht, 2008; Kelsall,   
2008; Udey and Nagao, 2008). In these tissues,   
CD103+ DCs have been identified that gener-
ally share the phenotype CD103+CD11blow/ 
DEC205+, and in the lung and skin also ex-
press the lectin Langerin. These CD103+ sub-
sets  appear  to  represent  migratory  cells  of   
similar phenotype and are identified in lymph 
nodes draining these tissues. In some studies,   
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Although CD103-expressing dendritic cells (DCs) are widely present in nonlymphoid tissues, 
the transcription factors controlling their development and their relationship to other DC 
subsets remain unclear. Mice lacking the transcription factor Batf3 have a defect in the 
development of CD8+ conventional DCs (cDCs) within lymphoid tissues. We demonstrate 
that Batf3/ mice also lack CD103+CD11b DCs in the lung, intestine, mesenteric lymph 
nodes (MLNs), dermis, and skin-draining lymph nodes. Notably, Batf3/ mice displayed 
reduced priming of CD8 T cells after pulmonary Sendai virus infection, with increased 
pulmonary inflammation. In the MLNs and intestine, Batf3 deficiency resulted in the 
specific lack of CD103+CD11b DCs, with the population of CD103+CD11b+ DCs remaining 
intact. Batf3/ mice showed no evidence of spontaneous gastrointestinal inflammation 
and had a normal contact hypersensitivity (CHS) response, despite previous suggestions 
that CD103+ DCs were required for immune homeostasis in the gut and CHS. The  
relationship between CD8+ cDCs and nonlymphoid CD103+ DCs implied by their shared  
dependence on Batf3 was further supported by similar patterns of gene expression and 
their shared developmental dependence on the transcription factor Irf8. These data  
provide evidence for a developmental relationship between lymphoid organ–resident  
CD8+ cDCs and nonlymphoid CD103+ DCs.
© 2010 Edelson et al.  This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months 
it is available under a Creative Commons License (Attribution–Noncommercial– 
Share  Alike  3.0  Unported  license,  as  described  at  http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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mice expressed Langerin by intracellular staining. In contrast, 
DCs from Batf3/ lungs showed no Langerin expression in 
any population. These results indicate that Batf3/ mice lack 
the CD103+ Langerin+ population of lung DCs rather than 
simply lacking expression of a single marker (Fig. 1 C).   
Finally, the loss of this CD103+ population was caused by a 
cell-intrinsic defect, because in mixed BM chimeras, donor-
derived Batf3/ lung DCs selectively lacked this population 
despite the normal development of CD103+ lung DCs from 
cotransferred WT BM (Fig. S1 A).
To analyze the role for lung CD103+ DCs in a viral 
pathogen model, we infected WT and Batf3/ mice in-
tranasally with SeV (Fig. 1, D and E; and Fig. S2). On day 8 
after infection, Batf3/ mice showed markedly decreased 
numbers of SeV-specific T cells, as measured by Kb-SeV 
NP 324–332 MHC pentamer staining (Cole et al., 1994). In 
agreement with reduced priming of CD8 T cells, Batf3/ 
mice showed greater weight loss after infection and had 
increased pulmonary inflammatory infiltrates on days 9 and 
15 after infection.
Microarray expression analysis of lung DCs
Based on shared functional properties between classical CD8+ 
cDCs and lung CD103+ DCs (Sung et al., 2006; del Rio et al., 
2007; Kim and Braciale, 2009), and their shared developmen-
tal requirement for Batf3, we next examined the transcrip-
tional profiles of lung and splenic cDC subsets by expression 
microarray analysis (Sung et al., 2006; Dudziak et al., 2007). 
Specifically, we compared purified CD103+CD11b and 
CD103CD11b+ lung DCs with splenic DEC205+ (surro-
gates for CD8+) or 33D1+ (surrogates for CD8) cDCs.
We compared the expression of transcription factors and 
receptors that are selectively expressed by subsets of splenic 
cDCs with their expression in subsets of lung DCs (Fig. 2, A 
and B). Batf3, which is highly expressed in both CD8+ and 
CD8 cDCs (Hildner et al., 2008), was also highly ex-
pressed in both lung DC populations (Fig. 2 A). Irf8 and Id2 
(Hacker et al., 2003; Kusunoki et al., 2003), which are   
required for CD8+ cDC development, are selectively ex-
pressed in the CD103+ subset of lung DCs. In a corresponding 
manner, Irf4, which is required for development of CD8 
splenic cDCs, is selectively expressed in the CD11b+ subset 
of lung DCs. Relb, reported to be required for development 
of CD8 cDC, (Wu et al., 1998), in contrast, was not   
differentially expressed between lung DC subsets.
Several surface markers also showed a correspondence 
between splenic and lung DC subsets. Itgae (CD103) and 
Cd207 (Langerin) were highly expressed in lung CD103+ 
DCs and also showed significant expression in CD8+ splenic 
cDCs. Likewise, CD24a and Ly75 (DEC205) also show a 
similar correspondence (Fig. 2 B). Several other receptors 
were selectively expressed more highly in CD11b+ lung DCs 
and splenic CD8 cDCs than in CD103+ lung DCs or 
CD8+ cDCs, including Itgam (CD11b), Emr1 (F4/80), and 
Sirpa (CD172a). In contrast, Cd8a and Cd4, which are useful 
for the discrimination of splenic cDCs, were not significantly 
peripheral CD103+ DCs have exhibited the specialized features 
of TLR3 responsiveness and the capacity for cross-presentation, 
suggesting a relationship with classical CD8+ DCs in lym-
phoid tissues, which themselves are CD103+CD11blow/neg 
DEC205+Langerinlow (Sung et al., 2006; del Rio et al., 2007; 
Bedoui et al., 2009).
We recently identified the transcription factor Batf3 as 
being  highly  expressed  in  cDCs  and  selectively  required 
for the development of CD8+ DCs of lymphoid tissues. 
Batf3/  mice  had  selective  defects  in  generating  CD8+  
T cell responses to a virus, cross-presentation, and rejection 
of syngeneic fibrosarcomas (Hildner et al., 2008). Batf3/ 
mice also had reduced numbers of CD103+CD8 cDCs in 
skin-draining lymph nodes (SDLNs; Hildner et al., 2008), a 
recently identified subset of peripheral cDCs (Bursch et al., 
2007; Ginhoux et al., 2007; Poulin et al., 2007). Because the 
developmental stages of DCs are still incompletely defined, 
the relationships between peripheral and lymphoid subsets 
of cDCs are unclear. Other transcription factors have been 
identified as important in the development of DCs (Merad 
and Manz, 2009). In particular, Irf8 mutant and Irf8-deficient   
mice also lack CD8+ cDCs but have additional immune   
defects (Holtschke et al., 1996; Aliberti et al., 2003; Tsujimura 
et al., 2003; Turcotte et al., 2005; Gabriele and Ozato, 2007; 
Tailor et al., 2008).
In this study, we extend our analysis of the roles of the 
transcription factors Batf3 and Irf8 in the development of 
lymphoid and nonlymphoid cDCs in mice. We determine 
that classical CD8+ cDCs and CD103-expressing DCs pres-
ent in diverse nonlymphoid tissues appear developmentally 
related based on similar requirements for both Batf3 and Irf8 
and similar patterns of gene expression. Further, we use 
Batf3/ mice to examine the role of CD103+ DCs in Sendai 
virus (SeV) infection of the lung, intestinal homeostasis, and 
skin-based contact hypersensitivity (CHS).
RESULTS
Batf3/ mice lack lung CD103+ DCs
The mouse lung and associated airways are known to con-
tain two distinct CD11c+ DC subsets (CD103+CD11b  
and CD103CD11b+) in addition to highly autofluorescent 
CD11c+CD103CD11b macrophages (GeurtsvanKessel and 
Lambrecht, 2008). We performed flow cytometry on cell 
suspensions of perfused, digested lungs from Batf3+/+ (WT) 
and Batf3/ mice (Fig. 1 A). After gating on CD45+CD11c+ 
cells (a mixture of DCs and macrophages), DCs were identi-
fied in the autofluorescentlow fraction and subdivided by 
CD103 and CD11b expression. Lungs from WT 129S6/
SvEv mice contain the two typical DC subsets in addition to 
a third CD103+CD11b+ (double-positive [DP]) population. 
This DP population has not been described previously but 
was  consistently  present  in  the  control  129S6/SvEv  mice 
used  in  analyzing  Batf3/  mice.  Strikingly,  129S6/SvEv 
background Batf3/ mice lacked both CD103+CD11b and 
DP lung DCs but had normal numbers of CD103CD11b+ 
lung DCs (Fig. 1, A and B). CD103+ lung DCs from WT JEM VOL. 207, April 12, 2010 
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expressed in lung DCs. Lastly, we examined the expression 
of the growth factor receptors Flt3 (the receptor for the DC 
growth factor Flt3L) and Csf1r (the receptor for M-CSF). 
Figure 1.  Batf3/ mice lack lung CD103+ DCs. (A) Cell suspensions of lung digests from Batf3+/+ and Batf3/ mice were stained for CD45, CD11c, 
autofluorescence (FITC channel; auto), CD11b, and CD103. Live CD45+CD11c+ cells, representing a mixture of lung macrophages and DCs, were initially 
gated (left), with the low autofluorescent population (DCs) further analyzed for the discrimination of three pulmonary DC subsets (right). Numbers repre-
sent the percentage of cells within the indicated gates. (B) Numbers of pulmonary DCs per mouse for each of the three pulmonary DC subsets as gated in A. 
Data represent the combination of two separate experiments, with each point representing the pooled lung cells from an individual mouse. Horizontal 
lines represent the mean cell number. (C) Cell suspensions of lung digests from Batf3+/+ and Batf3/ mice were stained for CD45, CD11c, CD11b, CD103, 
and intracellular Langerin. Live CD45+CD11c+ cells, representing a mixture of lung macrophages and DCs, were initially gated (left). A further gate was 
drawn to encompass all pulmonary DCs and exclude CD11bCD103 lung macrophages. These DCs were analyzed for the expression of CD103 and Lan-
gerin (right). Numbers represent the percentage of cells within the indicated gates. Staining was performed on two individual mice per group in one inde-
pendent trial. (D) Batf3+/+ and Batf3/ mice were infected with 100 PFU SeV intranasally or left uninfected (three or four uninfected mice per genotype; 
four infected mice per genotype). At day 8 after infection, SeV-specific CD8+ T cells were identified in cell suspensions of lung digests stained for CD19, 
Mac3, CD8, and Kb-SeV NP 324–332 MHC pentamers. CD8+CD19Mac3 cells were gated. Numbers represent the percentage of SeV-specific CD8+  
T cells. Data are representative of two separate experiments (one in which staining was performed at day 9 after infection). (E) Percentage of SeV-specific 
CD8+ T cells in the lungs of uninfected or infected mice, as stained in D. Horizontal lines represent the mean percentage.
Flt3 transcript was most abundant in both splenic subsets and 
in lung CD103+ cells, whereas Csf1r showed highest expres-
sion in lung CD11b+ cells (Fig. 2 C).826 Revealing relationships between DC subsets | Edelson et al.
population of CD4+Foxp3+ T reg cells in both the LP and 
MLNs (Fig. 3, C and D; and Fig. S3 D), with no evidence of 
inflammatory bowel disease in either the small intestine or 
colon (Fig. 3 E). In addition, CD4 and CD8 T cells from the 
LP and MLNs of Batf3/ mice showed normal expression of 
the gut-homing receptors 47 integrin and CCR9 (Fig. S4). 
There was no difference in the sensitivity of Batf3/ and 
WT mice to the dextran sodium sulfate (DSS) model of in-
duced colitis (Fig. S5; Brown et al., 2007).
Batf3/ mice lack dermal CD103+ DCs
CD103+Langerin+ DCs have been recently described as a 
unique, blood-derived migratory DC subset present in the 
dermis of mouse skin, and have been shown to traffic to 
SDLNs both in the steady state and during inflammation 
(Bursch et al., 2007; Ginhoux et al., 2007; Poulin et al., 
2007). These cells are distinct from CD103Langerin+ Lang-
erhans cells (LCs) of the epidermis and CD103Langerin 
Batf3/ mice lack intestinal CD103+CD11b DCs
Several intestinal DC subsets have been described in mice 
(Kelsall, 2008; Bogunovic et al., 2009; Varol et al., 2009). 
CD103+  DCs  of  the  lamina  propria  (LP)  and  mesenteric 
lymph nodes (MLNs) have been shown in vitro to promote 
the expression of specific integrins and chemokine receptors 
on T cells, and to direct the differentiation of CD4+Foxp3+ 
T reg cells, and are thought to be important components of 
intestinal homeostasis (Coombes and Powrie, 2008). Analysis 
of the LP and MLNs showed the absence of CD103+CD11b 
DCs in Batf3/ mice (Fig. 3, A and B; and Fig. S3, A–C), 
whereas  CD103+CD11b+  DCs  remained  present  in  these 
mice. MLNs of Batf3/ mice were found to lack the classical 
lymphoid  organ–resident  CD8+CD103low  cDCs  and  the 
LP-derived CD103+CD8low/ DCs (Fig. S3, A and B). Fur-
ther characterization of these subsets from WT mice revealed 
that only classical CD8+ cDCs express Langerin, whereas 
both subsets express DEC205. Batf3/ mice had a normal 
Figure 2.  Comparative microarray expression analysis of lung and splenic DC subsets. Microarray data for two lung DC and two splenic cDC 
subsets were normalized and modeled (three replicate arrays for each DC subset). Model-based expression indices were calculated using dChip soft-
ware for selected (A) transcription factors, (B) surface receptors, and (C) growth factor receptors. Values represent the mean index, with error bars 
representing the standard deviation.JEM VOL. 207, April 12, 2010 
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CD103Langerin+ LCs, both known to express DEC205+ 
and lack expression of CD8 (Fig. 4, B and C). Batf3/ 
mice again demonstrated the complete absence of CD103+ 
dermal DCs, with a normal population of LCs. As we have 
reported previously (Hildner et al., 2008), Batf3/ mice 
also lacked LangerinlowCD8+ cDCs in their SDLNs (Fig. 4 B). 
The loss of CD103+ dermal DCs in Batf3/ mice was caused 
by a cell-intrinsic defect, based on analysis of mixed BM 
chimeras (Fig. S1 B).
Irf8 mutant mice lack nonlymphoid CD103+ DCs
Irf8-deficient and BXH2 recombinant inbred mice, harbor-
ing a point mutation in the Irf8 gene, lack classical CD8+ 
cDCs of the spleen (Aliberti et al., 2003; Tailor et al., 2008). 
These strains also have other immune and hematopoietic   
abnormalities because of the actions of Irf8 in other cell types 
dermal DCs (Merad et al., 2008). Migratory LCs themselves 
are also present in the dermis of mice but are thought to rep-
resent cells trafficking toward SDLNs. We performed flow 
cytometry on cell suspensions prepared from the epidermis 
and dermis of WT and Batf3/ mice, and gated on DCs 
based on their expression of CD45 and CD11c (Fig. 4 A). 
Epidermal  LCs  were  present  normally  in  Batf3-deficient 
skin, whereas dermal preparations from these mice showed 
the absence of a small but distinct population of CD103+ 
Langerin+ dermal DCs. Gating on all Langerin-expressing 
cells  in  each  preparation  showed  the  normal  presence  of   
epidermal  and  dermal  CD103CD11b+  LCs  in  WT  and 
Batf3/ mice, whereas the latter mice clearly lacked the   
dermal CD103+CD11blow/ DC subset.
We next assessed SDLNs from WT and Batf3-deficient 
mice for the presence of CD103+Langerin+ dermal DCs and 
Figure 3.  Batf3/ mice lack intestinal CD103+CD11b DCs. (A) Cell suspensions of LP from Batf3+/+ and Batf3/ mice were stained for CD11c,  
I-Ab, CD11b, and CD103 (representative data from a single experiment involving two to three mice per group; two independent experiments were per-
formed). Live CD11chighI-Ab+ cells were gated. Numbers represent the percentage of cells within the indicated gates. (B) Percentage of CD103+CD11b  
LP DCs as gated in A. Horizontal lines represent the mean percentage. (C) Cell suspensions of LP from Batf3+/+ and Batf3/ mice were stained for CD3e, 
CD4, CD8, and intracellular Foxp3 (representative data from a single experiment with three mice per group). Live CD3e+CD4+CD8 T cells were gated. 
Numbers represent the percentage of cells within the indicated gates. (D) Percentage of Foxp3+ LP T cells as gated in C. Horizontal lines represent the 
mean percentage. (D) Light microscopy of H&E-stained sections of the small intestine and colon from Batf3+/+ and Batf3/ mice (data are representative 
of a single experiment involving two mice per group at 8–10 mo of age; a separate trial examined five mice per group at 3 mo of age with similar  
findings). Note the normal villous architecture and LP leukocytes, without evidence of inflammation. Bars: (left and right) 100 µm; (middle) 500 µm.828 Revealing relationships between DC subsets | Edelson et al.
Figure 4.  Batf3/ mice lack dermal CD103+ DCs. (A) Cell suspensions of epidermal and dermal digests from Batf3+/+ and Batf3/ mice were 
stained for CD45, CD11c, intracellular Langerin, CD103, and CD11b (representative data from a single experiment involving two mice per group). Live 
CD45+CD11c+ cells were initially gated (left), allowing for the discrimination of CD103Langerin+ LCs and CD103+Langerin+ dermal DCs. Langerin-express-
ing cells were gated for further analysis (right), allowing good discrimination of these two populations based on their differential expression of CD11b. 
Numbers represent the percentage of cells within the indicated gates. (B) Cell suspensions of pooled SDLNs from Batf3+/+ and Batf3/ mice were stained 
for CD11c, intracellular Langerin, CD103, DEC205, CD11b, and CD8 (representative data from a single experiment involving two mice per group; experi-
ments with similar combinations of stains have been performed in two other independent trials involving at least one mouse per genotype in each trial). 
Live CD11chigh cells were gated. Note the complete absence of CD103+Langerin+ dermal DCs (far left) and CD8+Langerinlow lymph node–resident DCs in 
Batf3/ mice. Langerin-expressing cells present in Batf3/ mice represent epidermal LCs. (C) Percentage and number of DCs per inguinal lymph node 
for three DC subsets. In this case, individual cell suspensions of inguinal lymph nodes (three mice per group, six lymph nodes total) were stained for 
CD11c, DEC205, CD8, CD103, and intracellular Langerin. Live CD11chigh cells were initially gated. Lymph node–resident DEC205+CD8+ cDCs were identi-
fied as a percentage of this gate. Migratory DCs were further gated as DEC205+CD8 cells, and Langerin+CD103+ dermal DCs and Langerin+CD103 LCs 
were identified as percentages of this gate. Horizontal lines represent the mean percentage and cell number.JEM VOL. 207, April 12, 2010 
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These findings show that nonlymphoid CD103+ DCs and 
CD8+ splenic cDCs share a developmental dependence on 
both Irf8 and Batf3.
Batf3/ mice display a normal CHS response
CHS is an inflammatory reaction of the skin mediated by 
hapten-specific T cells (Gocinski and Tigelaar, 1990). Sev-
eral studies have examined the role of epidermal LCs in   
the CHS response (Bennett et al., 2005; Kaplan et al., 2005; 
Kissenpfennig et al., 2005). Each of these groups used a dif-
ferent mouse model lacking LCs, and each came to a differ-
ent conclusion regarding the role of this DC subset in CHS. 
Two of these models used a diphtheria toxin receptor–based 
conditional depletion strategy to eliminate Langerin-expressing 
cells. However, it is now known that diphtheria toxin can 
deplete CD103+Langerin+ dermal DCs in addition to epidermal 
and  the  presence  of  a  replication-competent  endogenous 
mouse leukemia virus in BXH2 mice (Holtschke et al., 1996; 
Turcotte et al., 2005; Turcotte et al., 2007). However, in the 
cDC compartment of both strains, there is a selective absence 
of CD8+ DCs in vivo and the CD8+ surrogate population 
in Flt3L-derived BM cultures in vitro. Because of overlap-
ping effects of Irf8 and Batf3 deficiency, and high expression 
of Irf8 in CD103+ lung DCs (Fig. 2 A), we hypothesized 
that Irf8 mutant BXH2 mice would also lack development of 
nonlymphoid CD103+ DCs. Irf8 mutant mice lacked CD8+ 
splenic cDCs (Fig. 5 A), consistent with an earlier report 
(Tailor et al., 2008). As we predicted, we found that Irf8 
mutant mice lacked CD103+CD11b lung DCs (Fig. 5 B). 
In addition, Irf8 mutant mice lacked LP CD103+CD11b 
DCs (Fig. 5 C) and lacked both DEC205+CD8+ cDCs and 
CD103+DEC205+CD8 dermal DCs in SDLNs (Fig. 5 D). 
Figure 5.  Irf8 mutant mice lack nonlymphoid CD103+ DCs. (A) Cell suspensions of spleens from WT (B6C3HF1/J) and Irf8 mutant (BXH2) mice were 
stained for CD11c, CD11b, CD8, and DEC205 (representative data from a single experiment involving two mice per group; a second independent experi-
ment was performed with one mouse per group). Live CD11chigh cells were gated. Numbers represent the percentage of cells within the indicated gates.  
(B) Cell suspensions of lung digests from WT (B6C3HF1/J) and Irf8 mutant (BXH2) mice were stained for CD45, CD11c, CD11b, and CD103 (representative 
data from a single experiment involving two mice per group; two independent experiments were performed; a second independent experiment was per-
formed with one mouse per group). Live CD45+CD11c+ cells, representing a mixture of lung macrophages and DCs, were gated. Numbers represent the 
percentage of cells within the indicated gates. (C) Cell suspensions of LP from WT (C57BL/6) and Irf8 mutant (BXH2) mice were stained for CD11c, CD11b, 
and CD103 (representative data from a single experiment involving two mice per group; a second independent experiment was performed with one 
mouse per group). Live CD11chigh cells were gated. Numbers represent the percentage of cells within the indicated gates. (D) Cell suspensions of pooled 
SDLNs from WT (B6C3HF1/J) and Irf8 mutant (BXH2) mice were stained for CD11c, CD8, DEC205, CD11b, and CD103 (representative data from a single 
experiment involving two mice per group; a second independent experiment was performed with one mouse per group). Live CD11chigh cells were initially 
gated (left) to allow the identification of lymph node–resident DEC205+CD8+ cDCs. Migratory DCs were further gated as DEC205+CD8 cells and  
analyzed for their expression of CD11b and CD103. Numbers represent the percentage of cells within the indicated gates.830 Revealing relationships between DC subsets | Edelson et al.
DCs in CHS. Histological examination of the ears on day 2 
after elicitation showed significant edema and leukocyte infil-
tration in both WT and Batf3/ mice (Fig. 6 B). To rule out 
the possibility that our CHS protocol may have overlooked a 
role for CD103+ dermal DCs caused by the dose and sched-
ule of sensitization and elicitation, we performed a separate 
experiment in which three different protocols for DNFB-
based CHS were used (Fig. S6). In each case, Batf3/ mice 
displayed normal hapten-specific ear swelling in sensitized 
mice. In summary, our results together with previous studies 
indicate that epidermal LCs are sufficient to support CHS   
responses in the absence of CD103+ dermal DCs.
DISCUSSION
CD103+ DCs constitute a unified DC subset
We present evidence for a common developmental pathway 
for peripheral CD103+ DCs in lung, gut, and skin- and lym-
phoid organ–resident CD8+ cDCs. Conceivably, all pe-
ripheral CD103+ and lymphoid organ–resident CD8+ cDCs 
LCs in these mice (Bursch et al., 2007; Ginhoux et al., 2007; 
Poulin et al., 2007). Appropriate timing of diphtheria toxin 
treatment can allow for depletion of both Langerin-expressing 
cell types or the selective depletion of LCs (Bursch et al., 
2007; Wang et al., 2008). Using this approach, CHS responses 
were found to be diminished upon depletion of both epider-
mal LCs and dermal CD103+ DCs, but were normal upon 
depletion of only epidermal LCs (Bursch et al., 2007; Wang 
et al., 2008). By inference, these studies suggested that that 
dermal CD103+ DCs were sufficient for mediating CHS. 
  Because this conclusion was based on indirect evidence, we 
wished to test whether CHS responses were normal in Batf3-
deficient mice, which lack CD103+ dermal DCs but have 
normal epidermal LCs.
Mice were sensitized with 0.5% 1-fluoro-2,4-dinitro-
benzene (DNFB) on their abdomens 5 and 4 d before the elici-
tation of an ear-swelling response (Fig. 6 A). Batf3/ mice 
displayed normal hapten-specific ear swelling in sensitized 
mice, suggesting no absolute requirement for CD103+ dermal 
Figure 6.  Batf3/ mice display a normal CHS response. (A) Sensitized and nonsensitized Batf3+/+ and Batf3/ mice were treated on their ears 
with DNFB to elicit a hapten-specific CHS response. Ear swelling was measured at days 1 and 2 after elicitation. Each point represents an individual ear 
(three mice per group, six ears per group; Fig. S6 A shows an independent trial of this same protocol). Horizontal lines represent the mean. (B) Light mi-
croscopy of H&E-stained sections of treated ears from nonsensitized and sensitized Batf3+/+ and Batf3/ mice. Sensitized ears demonstrate edema and 
focal areas of leukocyte infiltration (arrowheads) composed largely of PMNs. Bars: (left) 1 mm; (right) 100 µm.JEM VOL. 207, April 12, 2010 
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monocytes and trace their differentiation into lung DCs. 
However, no monocyte transfer experiments were performed. 
It is not clear at this time whether lung CD103+ DCs repre-
sent a special class of CD103+ DCs that may arise from blood 
monocytes, or whether the manipulations used resulted in ad-
ditional pathways besides those operating in the steady state. 
Because Flt3 is expressed on CDPs and splenic cDCs but not 
blood monocytes (Kingston et al., 2009), it would be unex-
pected  for  monocytes  to  be  the  circulating  precursor  for 
CD103+ lung DCs, which themselves express high levels of 
Flt3 (Fig. 2 C). On the other hand, lung CD11b+ DCs and 
monocytes both express Csf1r (Fig. 2 C; Kingston et al., 2009), 
consistent with their developmental relationship.
Functions of peripheral CD103+ DCs
CD103+ DCs have been identified in individual anatomical 
locations. In the lung, CD103+ DCs were notable for their 
response to TLR3 stimulation and their ability to cross-present 
antigen to CD8+ T cells (Sung et al., 2006; del Rio et al., 
2007). Our microarray analysis confirms selective expression 
of Tlr3 on lung CD103+ DCs and splenic CD8+ cDCs. 
Some studies have suggested that lung CD103+ DCs prefer-
entially prime CD8+ T responses to respiratory influenza in-
fection (GeurtsvanKessel et al., 2008; Kim and Braciale, 
2009). One study made use of Langerin–diphtheria toxin   
receptor mice for the selective depletion of Langerin+CD103+ 
lung DCs (GeurtsvanKessel et al., 2008), finding reduced   
viral clearance and virus-specific CD8+ T cell priming in 
their absence (GeurtsvanKessel et al., 2008). A second study 
examined  the  differential  capacity  of  lung  DC  subsets  to 
prime CTLs and cross-present antigens ex vivo (Kim and 
Braciale, 2009). In agreement, our results now show that 
CD8 T cell responses to SeV are reduced in the absence of 
pulmonary CD103+ DCs. In contrast, a recent report has 
claimed that CD103CD11bhigh DCs of the lung were the 
dominant cell presenting antigen to CD8 T cells during in-
fluenza infection based on ex vivo analysis of their presenta-
tion capacity at the peak of infection, although both lung DC 
subsets presented antigen during early infection (Ballesteros-Tato 
et al., 2010). Further, CD70, which is selectively expressed 
by CD103CD11bhigh DCs, was important for the expansion 
of influenza-specific CD8 T cells, but no direct assessment of 
the requirement for CD103+ DCs for in vivo CD8 T cell   
responses to influenza was made. Infection of Batf3/ mice 
with influenza would help resolve this issue.
CD103+ DCs of the gut have been shown to exist in both 
mouse and human (Jaensson et al., 2008). Initial interest in 
this subset of gut DCs came after the observation that host 
CD103 expression on a non–T or –B cell population was 
important for the ability of T reg cells to ameliorate disease in 
a T cell transfer model of colitis (a model of inflammatory 
bowel disease induced by the transfer of CD4+CD45RBhigh 
T cells into severe combined immunodeficiency or Rag- 
deficient recipients; Annacker et al., 2005). Because a subset 
of gut DCs was the main cell type in these immunodeficient 
recipients expressing CD103, these authors set out to characterize 
constitute a single branch of cDC development sharing a 
common developmental precursor, developmental pathway, 
and overall function. Several papers over the last few years 
have collectively reported a pathway whereby BM common 
myeloid progenitors give rise to macrophage and DC precur-
sors, which give rise to common DC precursors (CDPs; Fogg 
et al., 2006; Naik et al., 2007; Onai et al., 2007; Auffray et al., 
2009a; Liu et al., 2009). In transfer experiments, CDPs are 
committed to give rise to pDCs, CD8+ cDCs, and CD8 
cDCs. In the BM, spleen, and blood, an intermediate cell, 
the pre-cDC, has been identified that gives rise only to cDC 
subsets but not pDCs (Liu et al., 2009). In contrast, blood 
monocytes are not precursors for splenic cDCs or pDCs, but 
in some settings may generate inflammatory DCs, epidermal 
LCs, and lung and gut CD11b+ DCs (León and Ardavin, 
2008; Auffray et al., 2009b; Bogunovic et al., 2009; Varol et al., 
2009). Based on these studies and our results, we suggest that 
pre-cDCs may also be blood-circulating precursors for CD103+ 
DCs in peripheral tissues.
During the review of our manuscript, a separate report 
also identified the developmental relationship between pe-
ripheral CD103+ DCs and lymphoid organ–resident CD8+ 
cDCs (Ginhoux et al., 2009). As in our experiments, Irf8 was 
found necessary for peripheral CD103+ DC development, 
but Batf3 was not examined. In addition, Id2 was required, in 
agreement with this factor’s role in CD8+ cDC develop-
ment (Hacker et al., 2003) and its higher expression in 
CD103+ DCs (Fig. 2 A). Using cell transfers, it was confirmed 
that pre-cDCs were in fact circulating precursors of periph-
eral tissue CD103+ DCs. In Batf3/ mice, we find that the 
number of pre-cDCs is normal (Fig. S7, A–C).
Gene expression data (Fig. 2 and Fig. S7 D) suggest a 
model in which Irf8 and Batf3 cooperate functionally to   
allow development of both lymphoid organ–resident CD8+ 
cDCs and peripheral tissue CD103+CD11b DCs. These 
two subsets share many features, including patterns of gene 
expression and their role in priming CD8 T cell responses. 
Irf8 is expressed early, beginning at the CDP, and remains 
highly expressed in the pre-cDC and in terminally differenti-
ated CD8+ and peripheral CD103+ DC subsets. Importantly, 
its expression is extinguished in lymphoid organ–resident 
CD8 cDCs, which also derive from the CDP/pre-cDC. 
In contrast, Batf3 becomes expressed only in the terminal 
stages of DC development, being highly expressed by both 
subsets of lymphoid organ–resident DCs and both subsets of 
peripheral DCs. However, the overlap of high Irf8 and Batf3 
expression is only found within the CD8+ and CD103+ 
subsets, suggesting cooperative interactions in their effects on 
functional development.
One report that is inconsistent with the hypothesis that 
pre-cDCs are the precursor for peripheral CD103+ DCs found 
that Ly6Chi monocytes may be the precursor for CD103+ 
lung DCs (Jakubzick et al., 2008). This study was based on the 
correlation  of  relative  frequencies  of  blood  Ly6Chigh  and   
Ly6Clow monocytes with lung CD103+ and CD11b+ DCs, 
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after DNA vaccination (Nagao et al., 2009), to be sufficient in 
the absence of LCs to support epicutaneous immunization to 
a foreign protein antigen, and to be efficient cross-presenting 
APCs for both viral and skin-derived self antigens (Wang et al., 
2008; Bedoui et al., 2009). It will be important to examine 
these responses in Batf3/ and Irf8/ or Irf8 mutant mice.
Previous studies indicated that CD103+ dermal DCs can 
support a normal CHS response in the absence of LCs, but 
that CHS was abrogated in the absence of both cell types 
(Bursch et al., 2007; Wang et al., 2008). Our data using 
Batf3/ mice represent the first CHS experiments in which 
CD103+ dermal DCs were selectively eliminated in the pres-
ence of a normal LC population. We show no absolute re-
quirement for this dermal DC subset in this response, and 
suggest that LCs are sufficient in this regard. However, it is 
possible that in the constitutive absence of CD103+ dermal 
DCs in Batf3/ mice, other cells not normally involved in 
CHS compensate for the loss of this subset.
Although Batf3 is highly expressed in lymphoid organ–
resident CD8+ and CD8 cDCs (Hildner et al., 2008), it 
is not required for the development of the CD8 cDC 
population. Likewise, Batf3 is expressed in both subsets of 
lung DCs but is only required for the development of the 
CD103+ subset. Thus, Batf3 is necessary but not sufficient for 
the development of CD8+ lymphoid organ–resident and 
CD103+ peripheral DC subsets. The transcription factors Irf8 
and Id2, required for CD8+ cDC development (Hacker et al., 
2003; Kusunoki et al., 2003), are more selectively expressed 
in CD8+ and CD103+ DC subsets but are also more widely 
expressed in non-DC lineages compared with Batf3. Thus, 
the development of DC subsets appears to be based on inter-
sections of both subset- and lineage-specific expression of 
transcription factors.
Our results reveal a developmental relationship between 
peripheral CD103+ DCs present in diverse anatomical loca-
tions, as well as a shared developmental relationship between 
these DCs and lymphoid organ–resident CD8+ cDCs. We 
show that all of these DC subsets depend on both Batf3 and 
Irf8 for their development. Numerous experimental systems 
including diverse vaccination and immunization strategies, 
and models of infection, transplantation, tumor immunity, and 
autoimmunity have assigned important functions to CD8+ 
cDCs (Heath et al., 2004; López-Bravo and Ardavin, 2008). 
Given that CD103+ DCs reside in virtually all peripheral 
  organs, their presence and activity should also be considered 
in these models.
MATERIALS AND METHODS
Mice. WT 129S6/SvEv, C57BL/6, and B6.SJL mice were purchased from 
Taconic. Batf3/ mice on a 129S6/SvEv background were previously gen-
erated in our laboratory (Hildner et al., 2008). Batf3/ mice were back-
crossed six generations to the C57BL/6 background for use in mixed BM 
chimera experiments. BXH2/TyJ (Irf8 mutant) mice, carrying a point muta-
tion in exon 7 of Irf8 resulting in an Arg to Cys change at amino acid 294 of 
the Irf8 protein (Turcotte et al., 2005), were purchased from the Jackson 
Laboratory. These mice are a recombinant inbred strain between C57BL/6 
and C3H/HeJ mice, and therefore B6C3HF1/J mice (The Jackson Laboratory) 
the function of this subset. These CD103+ DCs were reported 
to migrate in the steady state from the LP to the MLNs, and 
displayed the unique ability to induce the expression of the 
gut-homing receptors CCR9 and 47 integrin on T cells in 
vitro (Annacker et al., 2005; Johansson-Lindbom et al., 2005). 
Subsequent work also highlighted the unique ability of 
CD103+ DCs to induce the expression of the transcription 
factor Foxp3 in CD4+ T cells in vitro, a marker of T reg cell 
development (Coombes et al., 2007; Sun et al., 2007). CD103+ 
gut DCs were shown to selectively express genes necessary 
for the production of TGF- and retinoic acid when they 
were compared with CD103 gut DCs, and CD103+ DC 
induction of Foxp3 expression was shown to be dependent on 
both of these endogenously produced factors. More recently, 
mice made deficient in all gut DCs (using a CD11c–diphtheria 
toxin receptor transgenic system) and then reconstituted   
with  monocytes,  allowing  the  selective  repopulation  of 
CD103CD11b+ intestinal DCs, were found to be more sus-
ceptible to DSS-induced colitis, although no inflammation 
was observed in the absence of DSS treatment (Bogunovic   
et al., 2009; Varol et al., 2009). These data have led to the 
hypothesis that gut CD103+ DCs are important for the main-
tenance of self-tolerance in the intestine (Coombes and   
Powrie, 2008; Kelsall, 2008).
Our analysis of Batf3/ mice revealed the absence of 
CD103+CD11b DCs in both the LP and MLNs, and yet 
these mice displayed no evidence of spontaneous inflamma-
tion in their gastrointestinal tract and maintained a normal 
population of T reg cells in their LP and MLNs. Several pos-
sibilities might explain the lack of predicted gut inflammation 
in Batf3/ mice lacking CD103+ DCs. The presence of the 
CD103+CD11b+ DP LP DC subset in these mice may be 
sufficient to maintain homeostasis. In addition, other APCs 
in the LP or MLNs may be able to generate T reg cells in the 
gut.  Indeed,  LP  macrophages,  rather  than  CD103+  DCs, 
were recently reported to induce CD4+ T cell expression of 
Foxp3 in vitro (Denning et al., 2007). The LP of Batf3/ 
mice shows a normal population of macrophages. Thymically 
derived T reg cells may be sufficient for intestinal homeostasis, 
and we find no evidence of abnormal T reg cell development 
in Batf3/ mice. Finally, Batf3/ mice also lack classical 
CD8+ DCs in their MLNs, which may be required to prime 
T cells responses against intestinal flora.
We show Batf3 and Irf8 to be transcription factors required 
for the development of CD103+ dermal DCs. CD103+ dermal 
DCs represent a distinct population of cells, sharing the ex-
pression of Langerin with epidermal LCs. These two cell types 
have been recognized to differ in their radiosensitivity, their 
repopulation kinetics after conditional depletion, and their de-
velopmental requirements for TGF- (Bursch et al., 2007; 
Ginhoux et al., 2007; Poulin et al., 2007; Nagao et al., 2009). 
Both Batf3/ and Irf8 mutant mice selectively lack this   
skin-resident DC subset, in addition to their lack of lymphoid 
organ–resident  CD8+  cDCs,  while  maintaining  a  normal 
epidermal LC population. CD103+ dermal DCs have been re-
ported to play an important role in the presentation of antigen JEM VOL. 207, April 12, 2010 
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(5-mM final concentration) was added to cell suspensions, and cells were   
incubated on ice for 5 min. Cells were passed through a 40-µm strainer before 
red blood cells lysis with ACK lysis buffer. Cells were counted on a Vi-CELL 
analyzer, and 2–3 × 106 cells were used per antibody staining reaction.
Small intestinal LP cells were prepared from dissected small intestines   
after removal of Peyer’s patches and residual fat. Small (5-mm) pieces 
of  opened  intestine  were  washed  well  in  DPBS,  incubated  in  40  ml 
cIMDM for 45 min at 37°C with shaking at 250 rpm, vortexed, and 
washed again in cIMDM. Pieces were digested in 30 ml cIMDM with 
250 µg/ml collagenase B and 30 U/ml DNase I for 1 h at 37°C with stir-
ring. Cells were passed through a 40-µm strainer before resuspension in 
4 ml of 40% Percoll (Sigma-Aldrich). This suspension was overlaid with 
4 ml of 70% Percoll and centrifuged at room temperature for 20 min at 
900 g without braking. Cells were collected from the interface, washed 
with buffer (DPBS + 3% FCS + 0.02% sodium azide), counted, and 
stained for flow cytometry.
Dermal and epidermal cell suspensions were prepared from mouse ear 
skin. Dorsal and ventral ear flaps were teased apart with gentle traction, and 
individual flaps were digested in 3 ml cIMDM with 2 mg/ml Dispase II 
(Roche) for 2.5 h at 37°C with slow rotation in 6-well plates. Epidermal sheets 
generally “floated” off of the underlying dermis, although in some cases for-
ceps were used to fully separate the skin layers. Epidermal and dermal sheets 
were separately digested in a fashion identical to that described for lymph 
nodes to result in cell suspensions for antibody staining and flow cytometry.
Monocytes, pre-cDCs, and mature cDCs were isolated on a cell sorter 
(MoFlo; Dako). BM monocytes were identified as CD11b+Ly6Chigh cells, 
excluding CD11b+Ly6Cint neutrophils. Pre-cDCs from BM and spleen were 
identified  as  CD11c+CD43+SirpintI-AbCD11bB220Gr1CD4CD8 
cells after enrichment of CD11c+ cells by magnetic bead–based positive selec-
tion with anti-CD11c beads (Miltenyi Biotec). Mature cDCs from spleens 
were identified as either CD11c+CD8+DEC205+CD4CD11bB220 
DX5Thy1.2Gr1Ter119 or CD11c+CD4+CD11b+CD8DEC205 
B220DX5Thy1.2Gr1Ter119 cells after enrichment of CD11c+ cells by 
magnetic bead–based positive selection using anti-CD11c beads. RNA from 
these sorted cell populations was purified using RNeasy kits (QIAGEN).
CDPs from BM were isolated on a cell sorter (FACSAria II; BD) as   
c-KitintSca-1Flt3+CD115+CD11bCD11cB220Gr1Ter119CD3CD4 
CD8 cells. Cells were sorted directly into 1 ml of TRIzol reagent (Invitrogen), 
and 25 µl of linear acrylamide (Applied Biosystems) was added as a coprecipi-
tant. The aqueous phase was extracted with chloroform, and RNA was pre-
cipitated with 2-propanol, washed once with 75% ethanol, and resuspended in 
RNase-free water before quantitative real-time RT-PCR analysis.
Mixed BM chimeras. BM cells from femurs and tibias were collected from 
B6.SJL (CD45.1), C57BL/6 (CD45.2), and Batf3/ (CD45.2) mice (back-
crossed six generations to the C57BL/6 background). Two mixtures of BM 
cells were prepared at a 1:1 ratio: B6.SJL cells mixed with C57BL/6 cells, and 
B6.SJL cells mixed with Batf3/ cells. 20 million total BM cells were trans-
planted by intravenous injection into B6.SJL mice that had received 1,200 
rads of whole body irradiation on the day of transplant. Mixed chimeras were 
analyzed at 6 wk after transplant for the presence of DCs in the lungs and 
SDLNs, using antibodies specific for CD45.1 and CD45.2 to identify the 
donor cell of origin.
SeV infection. Sendai/52 virus (Fushimi strain) was purchased from the 
American Type Culture Collection and subjected to two rounds of in vitro 
plaque purification on Vero E6 cells. Afterward, a single clone was subjected 
to a round of amplification in embryonated chicken eggs. SeV was isolated 
from the allantoic fluid and diluted in PBS to generate a viral stock. Calcula-
tion of plaque-forming units was performed by standard plaque assay using 
either Vero E6 or LLC-MK2 cells. Mice were infected with 100 PFU of   
virus instilled intranasally. Mice were weighed at baseline and daily for 19 d. 
At the time points indicated in the figures, lungs were harvested and portions 
were fixed for histology. Remaining portions were digested for leukocyte 
preparation, and cells were stained and assayed by flow cytometry.
were used as WT controls for BXH2 mice in most experiments (although 
in some cases C57BL/6 mice were used as controls). Experiments were gen-
erally performed with sex-matched mice at 6–12 wk of age. Mice were bred 
and maintained in our specific pathogen–free animal facility according to 
  institutional guidelines with protocols approved by the Animal Studies 
Committee of Washington University.
Antibodies and flow cytometry. Staining was performed at 4°C in the 
presence of Fc Block (clone 2.4G2; BD) in FACS buffer (Dulbecco’s PBS 
[DPBS] + 0.5% BSA + 2 mm EDTA + 0.02% sodium azide). The following 
antibodies and secondary reagents were purchased from BD: biotin–anti–c-Kit 
(2B8), biotin–anti-CD3e (2C11), FITC–anti-CD3e (2C11), FITC–anti-Mac3   
(M3/84), FITC–anti-Ly6C (AL-21), FITC–anti-B220 (RA3-6B2), FITC–
anti–I-Ab (25-9-17), FITC–anti-Gr1 (RB6-8C5), PE–anti-Flt3 (A2F10.1), 
PE–anti–LPAM-1 (47 integrin, DATK32), PE–anti-CD43 (S7), PE–anti– 
I-Ab (AF6-120.1), PE–anti-CD11c (HL3), PE– and PE-Cy7–anti-CD11b 
(M1/70), PE-Cy7–anti-CD4 (RM4-5), PE-Cy7–anti-CD8 (53-6.7), 
PerCP Cy5.5–anti-CD45.1 (A20), allophycocyanin–anti-SIRP (P84),   
allophycocyanin–anti-CD8 (53-6.7), Alexa Fluor 700–anti-CD45.2 (104), 
streptavidin-PerCP, streptavidin–PE-Cy7, and streptavidin-allophycocyanin. 
The following antibodies and secondary reagents were purchased form 
eBioscience: biotin–anti-B220 (RA3-6B2), biotin–anti-CD49b (DX5), biotin– 
anti–Thy-1.2 (53-2.1), biotin–anti-Ter119 (Ter119), biotin–anti-CD103 
(2E7), FITC–anti-CD19 (ebio1D3), PE–anti-Flt3 (A2F10), PE–anti-CD103 
(2E7), PE–anti-Foxp3 (FKJ-16s), PE-Cy7–anti–c-Kit (2B8), allophycocya-
nin–anti-CD115 (AFS98), allophycocyanin–anti-CD45.2 (104), allophyco-
cyanin Alexa Fluor 750–anti-CD11c (N418), Alexa Fluor 700–anti–Sca-1 
(D7), allophycocyanin Alexa Fluor 750–anti-CD8a (53-6.72), allophycocya-
nin eFluor 780–anti-CD11c (N418), and streptavidin–allophycocyanin eFluor 
780. Alexa Fluor 488–anti-CD207/Langerin (929F3.01) was purchased   
from Imgenex. FITC–anti-CD8 (5H10), FITC–anti-CD4 (CT-CD4), 
allophycocyanin–anti-CD8 (5H10), and streptavidin–allophycocyanin-Cy7 
were  purchased  from  Invitrogen.  Allophycocyanin–anti-CD205/DEC205 
(NLDC-145) was purchased from Miltenyi Biotec. FITC–anti-CCR9 (242503) 
was purchased from R&D Systems. The following antibodies were main-
tained as hybridomas, with purified antibody conjugated to Pacific blue 
succinimidyl ester (Invitrogen): anti-CD11b (M1/70), anti-B220 (6B2), 
anti-Gr1 (RB6-8C5), anti-Ter119 (Ter119), anti-CD3e (2C11), anti-CD4 
(GK1.5), and anti-CD8 (53-6.7). Kb-SeV NP 324–332 (FAPGNYPAL) 
MHC pentamers were purchased from Proimmune.
For lung DC staining, samples were fixed in 4% formaldehyde for 15 min 
at room temperature after surface antibody staining and before use of strepta-
vidin reagents. For all experiments involving intracellular anti-Langerin stain-
ing, cells were surface antibody stained before fixation in 4% formaldehyde 
for 15 min at room temperature. Cells were subsequently permeabilized 
(DPBS + 0.1% BSA + 0.5% saponin) for 5 min at 4°C and stained in the same 
buffer with anti-Langerin and steptavidin reagents. Cells were washed twice 
in permeabilization buffer before returning them to FACS buffer. For intra-
cellular Foxp3 staining, cells were fixed and permeabilized with buffers pur-
chased as part of the Foxp3 staining buffer set (eBioscience). Flow cytometry 
was performed on a FACSCalibur, FACSCanto II, or LSR II (BD).
DC  preparation  and  cell  sorting. Lungs were perfused with 10 ml 
DPBS via injection into the right ventricle after transection of the lower 
aorta. Dissected lungs were minced and digested in 5 ml of Iscove’s modi-
fied Dulbecco’s media + 10% FCS (cIMDM) with 4 mg/ml collagenase D 
(Roche) for 1 h at 37°C with stirring. EDTA (5-mM final concentration) 
was added to cell suspensions, and cells were incubated on ice for 5 min. 
Cells were passed through a 40-µm strainer before red blood cells lysis with 
ACK lysis buffer. Cells were counted on an analyzer (Vi-CELL; Beckman 
Coulter), and 2–3 × 106 cells were used per antibody staining reaction.
Spleens, MLNs, and SDLNs (typically pooled cervical, brachial, axillary, 
and inguinal nodes, although in some cases inguinal nodes were analyzed sep-
arately) were digested in 5 ml cIMDM with 250 µg/ml collagenase B (Roche) 
and 30 U/ml DNase I (Sigma-Aldrich) for 1 h at 37°C with stirring. EDTA 834 Revealing relationships between DC subsets | Edelson et al.
Batf3/ mice. Fig. S2 demonstrates increased weight loss and pulmonary 
inflammation in Batf3/ mice infected with SeV. Fig. S3 shows an analysis 
of DCs and T reg cells from the MLNs of Batf3/ mice. Fig. S4 shows an 
analysis of homing receptor expression on intestinal T cells from Batf3/ 
mice.  Fig.  S5  demonstrates  normal  sensitivity  to  DSS-induced  colitis  in 
Batf3/ mice. Fig. S6 tests alternative protocols for the induction of CHS. 
Fig. S7 shows an analysis of pre-cDCs from Batf3/ mice, and shows quan-
titative RT-PCR data for the expression of Batf3 and Irf8 in developing and 
mature DC populations. Online supplemental material is available at http://
www.jem.org/cgi/content/full/jem.20091627/DC1.
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